Cargando…
Combination of Infliximab and High-Dose Intravenous Immunoglobulin for Toxic Epidermal Necrolysis: Successful Treatment of an Elderly Patient
Toxic epidermal necrolysis (TEN) is a rare, severe cutaneous adverse drug reaction with average mortality 25–35%, especially among elderly multimorbid patients. Established therapeutic guidelines do not exist and controversies underlie many of the presently suggested treatment regimens. Herein we pr...
Autores principales: | Patmanidis, Konstantinos, Sidiras, Anastasios, Dolianitis, Konstantinos, Simelidis, Dimitrios, Solomonidis, Christos, Gaitanis, Georgios, Bassukas, Ioannis D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505931/ https://www.ncbi.nlm.nih.gov/pubmed/23259092 http://dx.doi.org/10.1155/2012/915314 |
Ejemplares similares
-
Cephalosporin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin
por: Boroda, Konstantin, et al.
Publicado: (2015) -
Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis
por: Kian, Waleed, et al.
Publicado: (2021) -
Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine
por: Saavedra, Carlos, et al.
Publicado: (2012) -
Treatment of Toxic Epidermal Necrolysis With Immunoglobulins in a Burn Center
por: Cachafeiro Fuciños, L, et al.
Publicado: (2015) -
Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014)